From: Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease
Anti-CYP2D6
Anti-CYP2A6
Anti-CYP1A2
Chronic liver disease
+
-
AIH-2 (94–100%), HCV (0–10%)
HCV, APECED with or without hepatitis
AIH in APECED, drug induced hepatitis
HCV (0–7%)
AIH in APECED